---
title: "IN8bio (INAB.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/INAB.US/norm.md"
symbol: "INAB.US"
name: "IN8bio"
parent: "https://longbridge.com/en/quote/INAB.US.md"
datetime: "2026-06-14T02:29:57.574Z"
locales:
  - [en](https://longbridge.com/en/quote/INAB.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/INAB.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/INAB.US/norm.md)
---

# IN8bio (INAB.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.2615 | -0.6959 | -0.8493 | -1.24 | -1.99 |
| ROE | -80.89% | -97.03% | -108.46% | -139.96% | -156.59% |
| Revenue | - | - | - | - | - |
| Net income | -5.09M | -4.94M | -3.85M | -5.09M | -5.55M |
| Operating income | -5.27M | -5.03M | -3.97M | -5.20M | -5.66M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 26.27M | 32.28M | 16.77M | 19.37M | 19.87M |
| Leverage | 1.15 | 1.17 | 1.27 | 1.27 | 1.43 |
| BVPS | 2.31 | 2.82 | 2.87 | 3.74 | 5.12 |
| Turnover | - | - | - | - | - |
| Cash & STI | 21.94M | 27.09M | 10.69M | 13.23M | 11.89M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 3.25M | 4.04M | 4.56M | 5.08M | 6.60M |
| Net debt | -19.59M | -24.31M | -7.73M | -10.11M | -7.62M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -4.95M | -2.14M | -3.52M | -3.93M | -3.12M |
| Investing CF | -9000.00 | - | - | - | - |
| Financing CF | -195000.00 | 18.49M | 989000.00 | 5.27M | 3.89M |
| Free CF | -3.55M | -302625.00 | -2.22M | -1.90M | -1.13M |
| OCF coverage | -4264.66% | -1927.03% | -2865.04% | -1678.21% | -1387.56% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -9000.00 | - | - | - | - |